Edition:
United States

Zhongyuan Union Cell & Gene Engineering Corp Ltd (600645.SS)

600645.SS on Shanghai Stock Exchange

21.51CNY
26 May 2017
Change (% chg)

¥1.32 (+6.54%)
Prev Close
¥20.19
Open
¥20.20
Day's High
¥21.90
Day's Low
¥19.87
Volume
19,302,730
Avg. Vol
10,275,241
52-wk High
¥37.18
52-wk Low
¥18.81

Latest Key Developments (Source: Significant Developments)

Zhongyuan Union Cell and Gene Engineering unit to use 1.6 mln yuan to jointly set up diagnostic reagents development company
Tuesday, 1 Nov 2016 03:01am EDT 

Zhongyuan Union Cell and Gene Engineering <600645.SS>: Says its subsidiary Union Stemcell&Gene Engineering will use 1.6 million yuan to jointly set up a company in Tianjin . Says the new company with registered capital of 3.3 million yuan will be engaged in research and development of diagnostic reagents .Says the subsidiary will hold 49 percent stake in the new company.  Full Article

Zhongyuan Union Cell & Gene Engineering to establish unit
Tuesday, 30 Aug 2016 02:59am EDT 

Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS> : Says it will establish a wholly owned subsidiary, with a registered capital of 30 million yuan .The new subsidiary will be mainly engaged in adult cell tissue storage, biotechnology development and cellular genetic engineering industrialization businesses.  Full Article

Zhongyuan Union Cell & Gene Engineering to invest 10 mln yuan to set up unit
Monday, 9 May 2016 11:57pm EDT 

Zhongyuan Union Cell and Gene Engineering <600645.SS> : Says it to invest 10 million yuan establishing a new unit in Guangdong Province, with an investment management firm . Says the unit has a registered capital of 12 million yuan, and will be engaged in the development of biotechnology .Says company to hold 83.3 percent stake in the unit.  Full Article

Zhongyuan Union Cell & Gene Engineering says Top Gene boosts unit capital to 10.3 mln yuan
Monday, 9 May 2016 11:45pm EDT 

Zhongyuan Union Cell and Gene Engineering <600645.SS> : Says Top Gene to inject capital of 20 mln yuan in company's sub-unit, a Tianjin-based research institute, to acquire 3.2 pct stake in target co. .Says the unit's registered capital to expand to 10.3 million yuan.  Full Article

ZHONGYUAN UNION CELL & GENE ENGINEERING announces no dividend payment for 2015
Friday, 29 Apr 2016 08:00pm EDT 

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:Says no dividend payment for 2015.  Full Article

ZHONGYUAN UNION CELL & GENE ENGINEERING to establish new subsidiary in United States
Monday, 11 Apr 2016 08:00pm EDT 

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:To establish a wholly owned subsidiary in the United States, namely VcanBio Center for Translational Biotechnology Corp.The new subsidiary with a registered capital of $5 mln.  Full Article

ZHONGYUAN UNION CELL & GENE ENGINEERING to establish new subsidiary
Monday, 11 Apr 2016 08:00pm EDT 

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:Says establishment of a wholly owned subsidiary in Tianjin, with a registered capital of 5 mln yuan.The new subsidiary will be engaged in technology development of biotechnology field.  Full Article

ZHONGYUAN UNION CELL & GENE ENGINEERING to buy CAR-T technology and related patent
Monday, 11 Apr 2016 08:00pm EDT 

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:To buy chimeric antigen receptor T-cell immunotherapy (CD19-CAR-T and CD33-CAR-T) technology and related patents from Blood diseases hospital, Chinese Academy of Medical Science, for 58 mln yuan.Patent number of 201510233748.0 and 201510362934.4, respectively.  Full Article

ZHONGYUAN UNION CELL & GENE ENGINEERING subsidiary to establish new subsidiary
Monday, 11 Apr 2016 08:00pm EDT 

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:United States-based wholly owned subsidiary, Vcan Bio USA Co., Ltd. to establish a new subsidiary in U.S., namely HebeCell Corp.HebeCell Corp. with a registered capital of $5,007,200.The new subsidiary will be engaged in declaration work in U.S. of research and development product.  Full Article

ZHONGYUAN UNION CELL & GENE ENGINEERING to buy stake in Zhejiang-based pharmaceutical company
Tuesday, 5 Apr 2016 08:00pm EDT 

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:To buy 30.03 pct stake in Zhejiang-based pharmaceutical company (target company), from Shanghai-based company, for 12 mln yuan.To buy 12.58 pct stake in target company, from Jing Jie, for 8.5 mln yuan.To invest 50 mln yuan into the target company.To hold 67 pct in the target company, after the transaction.  Full Article

More From Around the Web